PMA device
Impella CP with SmartAssist
Abiomed, Inc. · Temporary Non-Roller Type Left Heart Support Blood Pump (OZD, Class III) · First FDA decision Mar 22, 2018, newest Feb 4, 2025Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
18
Naming "Impella CP"
MAUDE reports
21,680
Brand "Impella CP", since 2015
PubMed studies
477
Mentioning "Impella CP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Impella CP with SmartAssist
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Impella CP with SmartAssistPMA supplement
P140003-S122 · Decided Feb 4, 2025 · 97 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
P140003-S111 · Decided Dec 3, 2024 · 613 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
P140003-S099 · Decided Oct 28, 2022 · 179 days after receipt · Normal 180 Day Track
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Impella CP", any status and sponsor, newest update first.
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
University Hospital of CologneAcademic, hospital or other
NCT07655479 · 115 participants (planned) · Start Apr 23, 2026 · Primary completion Oct 2028
Device: Escalation to more capable microaxial flow-pump (Impella 5.5) · For: Cardiogenic Shock Post Myocardial Infarction
Sites: Düsseldorf, Germany; Kiel, Germany; Cologne, Germany
- Left Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive, not recruiting
Abiomed Inc.Public (JNJ)
NCT07943182 · 60 participants (planned) · Start Dec 3, 2024 · Primary completion Dec 2027
Device: Impella CP with SmartAssist; Impella 5.5 with SmartAssist · For: Cardiogenic Shock; Heart Failure; Acute Decompensated Heart Failure (ADHF) and 2 more
Sites: Phoenix, Arizona; Loma Linda, California; Los Angeles, California · 24 sites in all
15 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Impella CP", and for the whole product code for context.
This brand
21,680 reports: 5,907 malfunction, 13,040 injury, 2,729 death
Whole product code OZD
46,892 reports: 17,926 malfunction, 23,020 injury, 5,943 death
Newest reports for this brand
- Impella CPMalfunction
1220648-2026-14129 · Received Oct 30, 2026 · Event dated Oct 7, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Component Missing
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Impella CPInjury
1220648-2026-13912 · Received Oct 26, 2026 · Event dated Oct 2, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Hemolysis
- Impella CPDeath
1220648-2026-12978 · Received Sep 16, 2026 · Event dated Sep 13, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Failure to Advance; Malposition of Device
Patient problem as coded: Cardiac Arrest; Hemorrhage/Blood Loss/Bleeding
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.Open, Classified
Z-0208-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0209-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0210-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
22 more recall records with a free account
Published research
The most relevant PubMed records for "Impella CP"[tiab]. The summary above synthesizes these.
- Mechanical Circulatory Support with Impella: Principles, Evidence, and Daily Practice.
Masiero G, Arturi F, Panza A, et al. · J Clin Med · 2024Review
- Impella CP-assisted balloon aortic valvuloplasty.
Megaly M, Jones P · J Cardiol Cases · 2016
- Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock.
Møller JE, Engstrøm T, Jensen LO, et al. · N Engl J Med · 2024Comparative Study, Multicenter Study
- The Self-Expandable Impella CP (ECP) as a Mechanical Resuscitation Device.
Billig S, Zayat R, Yelenski S, et al. · Bioengineering (Basel) · 2024
- Cholecystectomy during Impella CP support in cardiogenic shock.
Baziak M, Jarocki M, Wietrzyk W, et al. · Postepy Kardiol Interwencyjnej · 2024
- Handling high-risk patients in the catheterization laboratory.
Ibrahim K, Tongers J, Mangner N, et al. · Eur Heart J Suppl · 2022
- Impella CP to Impella 5.5 Uninterrupted Upgrade Using a Double Device Technique.
Salas De Armas I, Patel MK, Akay M, et al. · ASAIO J · 2022
- Impella CP-Assisted Balloon Aortic Valvuloplasty in 2 High-Risk Patients.
Mohandes M, Fuertes M, Pernigotti A, et al. · J Tehran Heart Cent · 2024Case Reports
- Percutaneous Salvage of an Impella Pretzel.
Mathur M, Mohmand-Borkowski A, Harper M, et al. · JACC Case Rep · 2019
- Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI.
van den Buijs DMF, Wilgenhof A, Knaapen P, et al. · J Interv Cardiol · 2022Multicenter Study, Observational Study
- A femoral ImpellaTM CP plus REBOA for combined cardiogenic and haemorrhagic shock.
Vandenbriele C, Nijs S, Rega F, et al. · Acta Cardiol · 2023
- Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
Vergallo R, Pedicino D · Eur Heart J · 2024Comment
Other devices of this type
Also filed under product code OZD.
- Impella 2.5Abiomed, Inc. · PMA 2025
- Impella Ventricular Support SystemsAbiomed, Inc. · PMA 2023
- Impella 2.5, Impella CP and CP with SmartAssistAbiomed, Inc. · PMA 2023
- Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge CassetteAbiomed, Inc. · PMA 2025
- Impella Left Ventricular Support SystemsAbiomed, Inc. · PMA 2021
- Automated Impella ControllerAbiomed, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.